GeneDx Appoints Everett Cunningham as CEO, Reaffirms 2026 Financial Guidance
Trendline US

GeneDx Appoints Everett Cunningham as CEO, Reaffirms 2026 Financial Guidance

What's Happening? GeneDx, a genomic testing and rare disease diagnostics provider, has announced the appointment of Everett Cunningham as its new Chief Executive Officer and a member of its Board of Directors, effective on or before December 15, 2026. Cunningham will succeed Katherine Stueland, who
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.